NCT01175174

Brief Summary

Clinical, Airway Inflammatory, and HRA Phenotypes, in preschool children with acute asthmatic attack presenting to the ED. Background: Children under the age of 5 years have the highest hospitalization rate of asthma. The most common causes of acute exacerbations of asthma requiring urgent medical care are viral respiratory infections. Most of these children \< 6 y old are not atopic. The inflammatory response to these mostly viral-induced asthmatic attacks is not well characterized in the literature. Moreover it is not known whether different kind of inflammatory responses exist in this population and how this correlate to clinical outcomes and clinical phenotypes in preschool children presenting ti the ED with acute asthmatic attack. Therefore, the purpose of the present study is to: Investigate the characterization of induced sputum cytology in preschool children with acute asthmatic attack and whether there is correlation between specific sputum cytology and response to therapy and to investigate airways hyper-responsiveness to adenosine 5'-monophosphate and to metacholine in pre school children 2-6 y old at 2 weeks and at 3 month following acute asthmatic exacerbation and look for correlation with response to treatment and sputum cytology. Clinical phenotypes of this patient population will also be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 4, 2010

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
Last Updated

September 7, 2011

Status Verified

September 1, 2011

Enrollment Period

2.5 years

First QC Date

August 2, 2010

Last Update Submit

September 4, 2011

Conditions

Keywords

asthmapreschool childrenadenosine provocation testmetacholine provocation testpediatric emergency department

Outcome Measures

Primary Outcomes (2)

  • airways inflammatory phenotype

    Within 24 hours from admission to the emergency department (ED)

  • post attack bronchial hyperreactivity to adenosine 5'-monophosphate and to metacholine

    1. Within 2 weeks of recruitment 2. After 3 moths from recruitment

Secondary Outcomes (3)

  • Relationship between post attack bronchial hyperreactivity to adenosine 5'-monophosphate and to metacholine and the response to treatment and cytologic phenotypes.

    1. Within 3 weeks of recruitment 2. Beyond 3 moths from recruitment

  • relationship between cytologic phenotypes and response to treatment.

    Within 3 months of recruitmant

  • clinical phenotype

    whithin 1 month of presentation

Eligibility Criteria

Age1 Year - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children, age: 1-6 years old presenting to the emergency room (ER) with acute wheezing episode.

You may qualify if:

  • children, age: 1-6 years old
  • presenting to the ER with acute wheezing episode.

You may not qualify if:

  • Any chronic (lung, cardiac, immunologic, neurologic) disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Edith Wlofson Medical Center

Holon, Israel

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Avigdor Mandelberg, MD

    The Sackler School of Medicine, Tel Aviv University, Israel

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Pediatric Pulmonry Unit

Study Record Dates

First Submitted

August 2, 2010

First Posted

August 4, 2010

Study Start

January 1, 2009

Primary Completion

July 1, 2011

Study Completion

September 1, 2011

Last Updated

September 7, 2011

Record last verified: 2011-09

Locations